Market Research Reports

3,400+
Reports
16
Verticals
10yr
Forecasts
Filter:AllPharmaceuticalsMedical DevicesBiotechnologyHealthcare ITConsumer GoodsF&BChemicalsTechnologyPackagingSemiconductorAgricultureVeterinary

Surgical Robotics Simulation Market Size, Share & Trends Analysis Distribution by Product Type (Product, Services), By Application (General Surgery, Gynecological Surgery, Urological Surgery, Neurological Surgery (Head and Neck Surgery), Cardiological Surgery, Orthopedic Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Commercial Simulation Centres)- and Segment Forecasts, 2023-2031

Surgical Robotics Simulation Market Size is valued at USD 436.4 Mn in 2023 and is predicted to reach USD 1,283.6 Mn by the year 2031 at an 14.9% CAGR during the forecast period for 2024-2031. Surgical robotics involves advanced robotic systems that enhance surgeons' capabilities during procedures, offering improved precision and dexterity for complex minimally invasive surgeries. Equipped with features like high-definition 3D cameras and artic...

ID: 2575 180 Pages February 2025

Endoscopic Water Irrigation Pump Market Size, Share & Trends Analysis Report By Type (<300 ml/min, 300-500 ml/min, & >500 ml/min), By Application (Hospitals, and Clinics), By Region, And By Segment Forecasts, 2024-2031.

Endoscopic Water Irrigation Pump Market Size is valued at USD 93.7 Mn in 2023 and is predicted to reach USD 153.7 Mn by the year 2031 at a 6.5% CAGR during the forecast period for 2024-2031. An endoscopy water irrigation pump is a device used during endoscopic procedures to deliver sterile water or saline. It helps clear debris, improves visibility, and maintains a clean working field. Key features include controlled flow rates, compatibility ...

ID: 2574 180 Pages July 2024

Disseminated Intravascular Coagulation (DIC) Market Size, Share & Trends Analysis Report By Symptoms (Bleeding, Blood Clots, Bruising, Drop in Blood Pressure, Shortness of Breath, Confusion, Fever), Treatment (Medicines, Transfusions, Surgery), Diagnosis (Complete Blood Count with Blood Smear Exam, Partial Thromboplastin Time (PTT), Prothrombin Time (PT), Fibrinogen Blood Test, D-dimer), Route of Administration, End-Users, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031.

Disseminated Intravascular Coagulation (DIC) Market Size is valued at USD 437.3 Mn in 2023 and is predicted to reach USD 563.8 Mn by the year 2031 at a 3.3% CAGR during the forecast period for 2024-2031. The Disseminated Intravascular Coagulation (DIC) market focuses on managing a serious condition characterized by abnormal blood clotting, involving key segments such as diagnostics (e.g., D-dimer tests), therapeutics (anticoagulants and blood ...

ID: 2573 180 Pages July 2024

Secure Multiparty Computation (SMPC) Market Size, Share & Trends Analysis Report By Offering (Solution, Services), By Deployment Mode (Cloud, On-Premises), By Vertical (Banking, Financial Services, and Insurance (BFSI), IT & ITeS, Government, Healthcare, Retail and eCommerce), By Region, And By Segment Forecasts, 2024-2031.

Secure Multiparty Computation (SMPC) Market Size is valued at USD 766.9 Mn in 2023 and is predicted to reach USD 1,642.8 Mn by the year 2031 at a 10.26% CAGR during the forecast period for 2024-2031. The secure multiparty computation (SMPC) market revolves around technologies enabling multiple parties to compute a function collaboratively without revealing their private inputs. The growing demand for privacy-preserving computations in sectors ...

ID: 2572 180 Pages October 2024

Plant-based Spreads Market Size, Share & Trends Analysis Report By Type of Spreads (Lard, Margarine, Nut Butters, Legume-based spreads, Veggie Pâtés, Pestos, Guacamole, Hummus, Vegan Cream Cheese, Vegan Herring Salad, Jam, Others), By Source of Spreads, By Distribution Channel of Spreads, By Region, And By Segment Forecasts, 2025-2034.

Plant-based Spreads Market Size is valued at USD 486.82 Mn in 2024 and is predicted to reach USD 843.18 Mn by the year 2034 at a 5.8% CAGR during the forecast period for 2025-2034. Spreads are emerging as a popular breakfast choice for bread, driven by the increasing trend towards plant-based options in the market. Consumers are gravitating towards plant-based spreads for their health benefits, sustainability, and ethical considerations. The v...

ID: 2571 180 Pages June 2025

Single-strain Probiotics Market Size, Share & Trends Analysis Report By Business Model (B2B, Consumer, Hybrid), By Application/Health Benefit (Digestive, Immune, Pediatric, Oral, Specialized), By Product Form (Capsules, Powders, Liquids, Chewables/Tablets, Drops, Lozenges, Sachets), By Distribution Channel (Online Retail, Pharmacies/Drugstores, Supermarkets/Hypermarkets, Health Food Stores, B2B), By Microbiome Type, By End-Use Application, By Region, And By Segment Forecasts, 2025-2034

Single-strain Probiotics Market Size is predicted to grow at a 7.0% CAGR during the forecast period for 2025-2034.   Supplements and meals contain single-strain probiotics, which have different health benefits. These contain Lactobacillus rhamnosus GG for gut health and Bifidobacterium lactis for immunity. These drugs have targeted effects, scientific backing, and different potencies and storage needs. In capsules, powders, and fermented m...

ID: 2570 180 Pages May 2025

Recombinant Human Endostatin Market Size, Share & Trends Analysis Report By Type (purity 95% and others) And By Application (medical care, scientific research and others), By Region, And By Segment Forecasts, 2024-2031.

Recombinant Human Endostatin Market Size is valued at USD 133.3 Mn in 2023 and is predicted to reach USD 249.4 Mn by the year 2031 at a 8.3% CAGR during the forecast period for 2024-2031. Recombinant human endostatin is a naturally occurring protein in the human body that prevents angiogenesis and has been bioengineered. Genetic engineering methods are used to generate the recombinant form for medical uses. The increasing number of cancer case...

ID: 2569 180 Pages July 2024

Microbial Food Ingredient Market Share & Trends Analysis Report, By Type (Starter Cultures, Protective Cultures, Probiotic Cultures), By Application (Food, Drinks & Other), By Region, and Segment Forecasts, 2024-2031

Microbial Food Ingredient Market Size is valued at USD 2.49 Bn in 2023 and is predicted to reach USD 4.97 Bn by the year 2031 at an 9.2% CAGR during the forecast period for 2024-2031. Microorganisms are generating interest as an alternative food source because of their good nutritional profile, low carbon impact, and limited need for land and water. They are also resistant to seasonal fluctuations. The advent of new tools, particularly in synt...

ID: 2568 180 Pages July 2024

Radionuclide Drug Conjugates (RDC) Market Size, Share & Trends Analysis Distribution by Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma) and Segment Forecasts, 2024-2031

Radionuclide Drug Conjugates (RDC) Market Size is predicted to witness a 13.9% of CAGR during the forecast period for 2024-2031. Radionuclide Drug Conjugates (RDCs) represent a promising innovation in cancer treatment, utilizing a targeted approach to deliver radiation directly to tumor cells. By combining a radionuclide, targeting molecule, chelator, and linker, RDCs minimize harm to healthy tissues while effectively attacking cancer. This ta...

ID: 2567 180 Pages July 2024

Oligonucleotide Therapy Market Size, Share & Trends Analysis Report By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others), By Region, And By Segment Forecasts, 2024-2031.

Oligonucleotide Therapy Market Size is valued at USD 5.21 billion in 2023 and is predicted to reach USD 19.92 billion by the year 2031 at a 18.6% CAGR during the forecast period for 2024-2031. Oligonucleotides are some of the most promising therapeutic mechanisms for a range of hard-to-treat diseases, in particular those caused by genetic mutations. These are Short sequences of artificially created DNA or RNA molecules that attach to matching ...

ID: 2566 180 Pages October 2024

Long Acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered, Material Used And End-User, Region And Segment Forecasts, 2023-2031

Global Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031 at a 10.6% CAGR during the forecast period for 2024-2031. The global long-acting drug delivery technologies and services market is witnessing robust growth due to the demand for improved patient adherence and therapeutic outcomes. Long-acting formulations, including injectables and implants,...

ID: 2565 180 Pages July 2024

Personalized Psychiatry Market Size, Share & Trends Analysis Report, By Type (Products, Services, Software), By Therapeutic Areas (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Others), By Region, Forecasts, 2024-2031

Personalized Psychiatry Market Size was valued at USD 4.2 Bn in 2023 and is predicted to reach USD 10.1 Bn by 2031 at a 11.8% CAGR during the forecast period for 2024-2031. Personalized psychiatry is a method of treating mental health issues that takes into account the unique qualities of each patient. It entails tailoring treatment programs to each personalized specific health issue by analyzing their genetic makeup in conjunction with their ...

ID: 2564 180 Pages July 2024

Cancer Biomarker Market Size, Share and Trends Report 2026 to 2035

What is  Cancer Biomarker Market Size? Global Cancer Biomarker Market Size was valued at USD 27.28 Bn in 2025 and is predicted to reach USD 41.47 Bn by 2035 at a 4.4% CAGR during the forecast period for 2026 to 2035. Cancer Biomarker Market Size, Share & Trends Analysis Report, by Type of Biomarker (HER2, MET, EGFR, PD-L1, NTRK, ALK, Novel Biomarkers and Other Biomarkers), Type of Cancer (Breast Cancer, Prostate Cancer, Color...

ID: 2563 180 Pages March 2026

Fire Resistant Tapes Market Size, Share & Trends Analysis Report By Coating Type (Single Coated, Double Coated), By Type (Nomex, Acetate, PPS, Glass Cloth, PVC, Polyimide, Others), By End-Use (Industries, Building & Construction, Electrical & Electronics, Automotive, Aerospace & Defense Others), By Region, And By Segment Forecasts, 2024-2031.

Fire Resistant Tapes Market Size is valued at USD 0.78 billion in 2023 and is predicted to reach USD 1.33 billion by the year 2031 at a 7.1% CAGR during the forecast period for 2024-2031. Fire resistant tape is a type of adhesive tape specifically designed to resist or slow down the spread of flames in case of a fire. The primary purpose of fire resistant tape is to enhance the fire safety of materials or products to which it is applied. This ...

ID: 2562 180 Pages February 2025

Insulin-like Growth Factors Market Share & Trends Analysis Report, By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), By Region, and Segment Forecasts, 2023-2031

Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 at an 5.13% CAGR during the forecast period for 2024-2031. Insulin-like growth factors (IGFs) are proteins that resemble insulin in structure and share some of its effects. Their primary function, however, is to stimulate cell growth and development throughout the body, forming part of a complex system known as the ...

ID: 2561 180 Pages July 2024

Organ on Chip Market Size and Revenue Impact Study 2026 to 2035

What is Organ on Chip Market Size? Organ on Chip Market Size is valued at USD 155.77 Mn in 2025 and is predicted to reach USD 3188.14 Mn by the year 2035 at a 35.70% CAGR during the forecast period for 2026 to 2035. Organ on Chip Market Size, Share & Trends Analysis By Organ Type (Liver, Kidney, Intestine, Lung, Heart, Other Organs), By Model Type (Organ-based Models, Disease-based Models), By Product & Service (Services (Custom Service...

ID: 2560 180 Pages January 2026

Direct Primary Care Market Size, Share and Trends Report 2026 to 2035

What is Direct Primary Care Market Size? Direct Primary Care Market Size is valued at USD 59.68 Bn in 2025 and is predicted to reach USD 92.46 Bn by the year 2035 at an 4.6% CAGR during the forecast period for 2026 to 2035. Direct Primary Care Market Share & Trends Analysis Report By Type (Clinical services, Telehealth services, Laboratory services, Consultative services, Others (Vaccinations and immunization visits, etc.)), By Ca...

ID: 2559 180 Pages February 2026

Monolith Chromatography Columns for Advanced Therapeutics Market Size, Share Detailed Report 2025 to 2034

Global Monolith Chromatography Columns for Advanced Therapeutics Market Size is valued at USD 286.1 Mn in 2024 and is predicted to reach USD 1,342.5 Mn by the year 2034 at an 17.0% CAGR during the forecast period for 2025 to 2034. Monolith Chromatography Columns for Advanced Therapeutics Market Size, Share & Trends Analysis Distribution By Product Type (Analytical Monoliths, Preparative Monoliths, Process-Scale Monoliths), By Material (Polym...

ID: 2558 180 Pages January 2026

Cytotoxic Drugs and HPAPI Manufacturing Market Size, Share, Trend Report 2026 to 2035

What is Cytotoxic Drugs and HPAPI Manufacturing Market Size? Cytotoxic Drugs and HPAPI Manufacturing Market Size is valued at USD 15.71 Bn in 2025 and is predicted to reach USD 52.74 Bn by the year 2035 at an 13.0% CAGR during the forecast period for 2026 to 2035. Cytotoxic Drugs and HPAPI Manufacturing Market Size, Share & Trends Analysis Distribution by Type of Product (HPAPI and highly potent finished dosage form), Company Size...

ID: 2557 180 Pages March 2026

Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market Size, Share & Trends Analysis by Disease (Neurological Disorders and Dystrophies, Cardiac disorders, Retinal Eye Disease, Metabolic Disorders, Liver disease, Others), Products and Services (Disease Model, Reprogramming service, Differentiation service, Screening service, Characterization service, Others), and Segment Forecasts, 2023-2031

Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model   Market Size is predicted to grow at an 11.2% CAGR during the forecast period for 2024-2031. Human-induced pluripotent stem cells (hiPSCs) are a pivotal tool in biomedical research, particularly for preclinical disease modelling and drug development. Derived from adult somatic cells like skin or blood cells, hiPSCs are reprogrammed to an embryonic-like pluripote...

ID: 2556 180 Pages July 2024